Jamy Ard, Co-Director, Weight Management Center at Wake Forest Baptist Health This article dives into how brands can use science-backed ingredient solutions to create high-protein, high-fiber, nutrient-dense products that resonate with GLP-1-era consumers
Clinics generally advise against starting treatment for anyone who: Is pregnant Has a personal or family history of thyroid cancer Has a history of multiple endocrine neoplasia (MEN) syndrome BMI and health history serve as a useful starting point for this evaluation, not an absolute cutoff, since metabolism and overall wellness also weigh into a provider's decision
Treatments like Wegovy and Zepbound (known as GLP-1 medications) are helping many people lose an average of 15% to 21% of their body weight, especially when combined with healthy eating, regular movement, and sustainable lifestyle changes
Sustained weight loss over the long term is challenging, with or without medication
5 vials